After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a uncommon autoimmune situation the ...
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a uncommon autoimmune situation the ...
A brand new College of Utah-led examine has found the mechanism behind a decades-old evolutionary mystery-how "egocentric chromosomes" cheat the ...
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.